pci-32765 has been researched along with Splenic-Rupture* in 3 studies
3 other study(ies) available for pci-32765 and Splenic-Rupture
| Article | Year |
|---|---|
Fatal splenic rupture after discontinuing treatment by ibrutinib and venetoclax in relapse/refractory mantle cell lymphoma.
Topics: Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Lymphoma, Mantle-Cell; Male; Neoplasm Recurrence, Local; Piperidines; Splenic Rupture; Sulfonamides; Treatment Failure; Withholding Treatment | 2021 |
Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib.
Topics: Adenine; Aged; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Piperidines; Pyrazoles; Pyrimidines; Splenic Rupture | 2018 |
Splenic rupture following temporary cessation of ibrutinib.
Topics: Adenine; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Pyrazoles; Pyrimidines; Splenic Rupture; Time Factors; Tomography, X-Ray Computed | 2017 |